Prescott Group Capital Management L.L.C. Makes New $1.94 Million Investment in Medifast, Inc. (NYSE:MED)

Prescott Group Capital Management L.L.C. acquired a new position in Medifast, Inc. (NYSE:MED - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 110,000 shares of the specialty retailer's stock, valued at approximately $1,938,000. Prescott Group Capital Management L.L.C. owned approximately 1.01% of Medifast at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quarry LP lifted its stake in shares of Medifast by 148.6% in the third quarter. Quarry LP now owns 6,629 shares of the specialty retailer's stock worth $127,000 after acquiring an additional 3,962 shares in the last quarter. Public Employees Retirement System of Ohio raised its position in shares of Medifast by 1,161.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer's stock valued at $187,000 after purchasing an additional 8,992 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Medifast by 2,308.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock valued at $202,000 after buying an additional 10,967 shares during the last quarter. Benjamin Edwards Inc. purchased a new position in shares of Medifast during the 3rd quarter valued at approximately $256,000. Finally, Centiva Capital LP grew its position in shares of Medifast by 6.3% during the third quarter. Centiva Capital LP now owns 15,238 shares of the specialty retailer's stock worth $292,000 after buying an additional 898 shares in the last quarter. 95.51% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Medifast Stock Performance

Shares of NYSE MED traded down $0.72 during trading on Tuesday, reaching $14.32. The stock had a trading volume of 280,084 shares, compared to its average volume of 339,723. The stock has a market cap of $156.63 million, a PE ratio of 79.56 and a beta of 1.13. Medifast, Inc. has a one year low of $13.57 and a one year high of $40.11. The firm's 50 day moving average price is $15.45 and its two-hundred day moving average price is $17.52.

Medifast (NYSE:MED - Get Free Report) last released its earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.26. Medifast had a net margin of 0.35% and a return on equity of 10.64%. The firm had revenue of $119.00 million during the quarter, compared to analyst estimates of $114.25 million. On average, research analysts expect that Medifast, Inc. will post 0.51 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, DA Davidson decreased their price target on Medifast from $17.00 to $16.50 and set a "neutral" rating for the company in a research note on Wednesday, February 19th.

Medifast Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.